Blog

View all posts

The government’s trade agenda threatens disastrous deregulation – but we can stop it

Nick Dearden
Nick Dearden, photo by Genevieve Stevenson

15 January 2021
Trade justice

The Brexit trade deal with the EU might be completed, but the type of country Britain becomes next is still to be defined - and trade rules will play a key role in shaping our future. That’s why we need to keep campaigning on trade in the month and years ahead.  

What we've stood for together in 2020

Global Justice Now

21 December 2020
General

We have lived through 12 months dominated by coronavirus – a disease which has exposed the fragility and inequality of the global economy like nothing before. This virus has turned our world upside down, and we want to offer our heartfelt thanks for your support in such a difficult time. 

Three things I don’t want to find in my Christmas stocking

Liz Murray

19 December 2020
Trade justice

Why we need to stop a US-UK trade deal if we don't wanted banned chemicals in our Christmas presents.

Latest news

View all news

Big Pharma model is serious obstacle to wiping out Covid-19, new report suggests

Pharma

New research released today by Global Justice Now examines the history of some of the leading corporations producing coronavirus medicines, warning that their business model is likely to make controlling the pandemic more difficult, despite the rapid production of vaccines.

MSPs call on Westminster to back suspension of patents on Covid-19 vaccines

Coronavirus
Pharma

Thirty seven MSPs, from across the parties, have written to the UK government ahead of an important international meeting to call on them to support a proposal to make Covid-19 vaccines and treatments affordable to all countries, not just the richest.

Campaigners warn that 9 out of 10 people in poor countries are set to miss out on Covid-19 vaccine next year

Coronavirus

Nearly 70 poor countries will only be able to vaccinate one in ten people against Covid-19 next year unless urgent action is taken by governments and the pharmaceutical industry to make sure enough doses are produced, a group of campaigning organisations warned today, as the UK begins to rollout vaccinations.